Sending patients heaps of medical supplies to score more money from insurers is common in the device industry. If insurers decline to cover the supplies, patients are stuck paying for materials they ...

Zynex shares are up ~100x since late 2016 as retail investors buy into a story of rapid revenue and earnings growth. However, we believe Zynex is dependent on an abusive pricing strategy - reselling ...

Two executives of a Colorado-based medical device company are still awaiting their day in court. Former Zynex CEO 67-year-old Thomas Sandgaard of Castle Rock and former COO 39-year-old Anna Lucsok of ...

A federal grand jury in Rhode Island has charged two former top executives of Colorado-based medical device company Zynex Inc. with fraud, accusing them of raking in hundreds of millions of dollars ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The new insurance deal offers ...

ENGLEWOOD, Colo., Feb. 17, 2026 /PRNewswire/ -- Zynex, Inc., today announced that it has resolved the federal government's investigation into business practices designed and implemented by the company ...

Zynex missed on second-quarter revenue and earnings, and guided down. However, some of the near-term weakness was by design, as the company is cutting costs. The stock looks very cheap if the company ...

Throughout the last three months, 4 analysts have evaluated Zynex (NASDAQ:ZYXI), offering a diverse set of opinions from bullish to bearish. The table below provides a concise overview of recent ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...